Morgan Stanley's Investment Position: Outlook for Q1 2024

Source: seeingalpha.com Consensus Revenue Estimates Consensus revenue estimates provide insight into Morgan Stanley’s expected revenue performance for the same accounting periods as EPS forecasts—namely, ending March 2024 (Q1) and June 2024 (Q2). For Q1 2024, revenue is projected at $14.36 billion, representing a year-over-year decline of -1.11%. This indicates a slight decrease compared to the prior-year period. The revenue estimates from 14 analysts range from $13.69 billion to $14.75 billion. Although growth is negative, the firm is still expected to generate substantial revenue, albeit marginally lower than the previous year. For Q2 2024, revenue is forecast at $14.1 billion, reflecting a year-over-year growth rate of 4.79%. This suggests a more optimistic revenue outlook relative to Q1. The revenue estimates from 14 analysts range from $13.23 billion to $14.67 billion. Unlike EPS forecasts, Q2 revenue projections exceed those for Q1—indicating potential improvement in revenue performance as the fiscal year progresses. Consensus EPS Revision Trends Consensus EPS revision trends reflect how analysts’ expectations for Morgan Stanley’s earnings per share have evolved over time. For Q1 2024, EPS forecasts have undergone downward revisions over the past one, three, and six months. The one-month trend shows a revision of -1.08%, while the three- and six-month trends show revisions of -1.53% and -12.53%, respectively. These negative trends suggest a sustained decline in analyst expectations for Q1 earnings performance, reflecting potential challenges or uncertainties facing the company during this period. For Q2 2024, EPS forecasts have also experienced downward revisions over the past one, three, and six months—but to a relatively smaller extent. The one-month trend shows a minor revision of +0.07%, while the three- and six-month trends show revisions of -2.71% and -13.20%, respectively. Although downward revisions persist, the trend suggests comparatively greater stability in Q2 earnings expectations relative to Q1. Consensus Revenue Revision Trends Similar to EPS revision trends, consensus revenue revision trends indicate how analysts’ expectations for Morgan Stanley’s revenue have changed over time. For Q1 2024, revenue forecasts have undergone downward revisions over the past one, three, and six months. The one-month trend shows a revision of -0.21%, while the three- and six-month trends show revisions of +0.18% and -5.01%, respectively. Although downward revisions occurred, the most recent one-month trend suggests revenue expectations for Q1 may be stabilizing—albeit at a slightly lower level than earlier expectations. For Q2 2024, revenue forecasts have been consistently upgraded over the past one, three, and six months. The one-month trend shows a revision of +0.36%, while the three- and six-month trends show revisions of +0.70% and -4.51%, respectively. These positive trends indicate growing analyst confidence in the company’s Q2 revenue performance, reflecting an improved revenue growth outlook relative to Q1.

What factors does Morgan Stanley typically consider when evaluating stocks?

Morgan Stanley is a renowned global financial services firm with a well-established framework for stock evaluation. It considers a comprehensive and multifaceted set of factors to form thorough analyses and investment recommendations. Common evaluation criteria include: 1. Fundamental Analysis: - Revenue and Profitability: Assessing the company’s revenue growth trajectory, profitability, quality of earnings, and future earnings expectations. - Financial Position: Reviewing the company’s balance sheet to understand its debt levels, cash flow status, and capital structure. - Operational Efficiency: Analyzing operational efficiency metrics such as sales turnover ratio, inventory turnover ratio, and return on assets. 2. Valuation Analysis: - Price-to-Earnings (P/E) Ratio: Comparing the company’s P/E ratio with those of peers in the same industry. - Price-to-Book (P/B) Ratio: Evaluating the stock price relative to the company’s book value. - Enterprise Value-to-EBITDA (EV/EBITDA): Measuring enterprise value against earnings before interest, taxes, depreciation, and amortization to assess the relationship between company value and earning power.

Morgan Stanley Adjusts PT on Air Products and Chemicals to $320 From $310, Keeps Equalweight Rating

Aug 3, 2026

Morgan Stanley raised its price target for Air Products and Chemicals to $320 from $310, maintaining an Equalweight rating following a Q3 2026 earnings beat. Multiple other banks have also recently updated their price targets for the company.

marketscreener.com

2026-04-14

Citi Maintains Hold Rating on Air Products and Chemicals (APD)

2026-04-21

Positive Report for Air Products and Chemicals (APD) from Berenberg Bank

2026-04-22

Air Products and Chemicals (APD) Stock Crosses Above 20-Day Moving Average

2026-04-24

Air Products Expands Core Gases Network With New Florida Facility Plan

2026-04-27

Wolfe Research raises Air Products stock price target on hydrogen demand